October 29: The Week in Cancer News
Patient expenses for cancer care exceed $21 billion in 2019, the FDA introduces stringent requirements for breast implants and more news of the week from Cancer Today.
Progress Against Cancer
Patient expenses for cancer care exceed $21 billion in 2019, the FDA introduces stringent requirements for breast implants and more news of the week from Cancer Today.
Liver cancer is the second most common cause of cancer-related deaths worldwide. In 2021, it is estimated that more than 42,000 people will be diagnosed with the disease and approximately 30,000 will die because...
On Wednesday, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report. Now in its 11th year, the report details advances in the cancer research continuum, provides a comprehensive review of anticancer drugs, diagnostic tools, and devices approved by the U.S. Food and Drug Administration in the past year, shines a...
study shows the cost of drugs that manage cancer-related symptoms adds up, and more news of the week from Cancer Today magazine.
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway on Wednesday, a trio of keynote speakers provided different perspectives on this critical field of research. The...
Researchers create breast cancer prediction models tailored for Asian Americans.
MRI can be a cost-effective way to screen for breast cancer, and more news of the week from Cancer Today.
On a web page titled “14 Diseases You Almost Forgot About (Thanks to Vaccines),” the Centers for Disease Control (CDC) remind us that the United States has eliminated or drastically reduced cases of several diseases—such as polio, measles, and...
Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and more news of the week from Cancer Today.
With targeted drugs, immunotherapies and treatment combinations now available, people with advanced melanoma have choices to make.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 49,000 members worldwide drive progress against cancer.
Donate Now